| __timestamp | HUTCHMED (China) Limited | Viking Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 26684000 | 1244910 |
| Thursday, January 1, 2015 | 29829000 | 5029636 |
| Friday, January 1, 2016 | 39578000 | 4846776 |
| Sunday, January 1, 2017 | 43277000 | 5329003 |
| Monday, January 1, 2018 | 48645000 | 7121000 |
| Tuesday, January 1, 2019 | 52934000 | 9128000 |
| Wednesday, January 1, 2020 | 61349000 | 10731000 |
| Friday, January 1, 2021 | 127125000 | 10701000 |
| Saturday, January 1, 2022 | 136106000 | 16121000 |
| Sunday, January 1, 2023 | 133175999 | 37021000 |
Data in motion
In the ever-evolving landscape of the pharmaceutical industry, operational efficiency is paramount. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of two prominent players: Viking Therapeutics, Inc. and HUTCHMED (China) Limited, from 2014 to 2023.
HUTCHMED has consistently outpaced Viking in SG&A spending, with a staggering 400% increase from 2014 to 2023. In 2023, HUTCHMED's expenses peaked at approximately 133 million, marking a 5% decrease from the previous year. Conversely, Viking's SG&A expenses surged by nearly 300% over the same period, reaching 37 million in 2023.
These trends highlight HUTCHMED's aggressive market expansion and Viking's strategic scaling. Investors and stakeholders should consider these financial dynamics when evaluating potential growth and operational strategies.
SG&A Efficiency Analysis: Comparing Novo Nordisk A/S and HUTCHMED (China) Limited
Who Optimizes SG&A Costs Better? Merck & Co., Inc. or Viking Therapeutics, Inc.
AstraZeneca PLC vs Viking Therapeutics, Inc.: SG&A Expense Trends
Breaking Down SG&A Expenses: Amgen Inc. vs Viking Therapeutics, Inc.
United Therapeutics Corporation or HUTCHMED (China) Limited: Who Manages SG&A Costs Better?
Cost Management Insights: SG&A Expenses for Neurocrine Biosciences, Inc. and Viking Therapeutics, Inc.
Comparing SG&A Expenses: Insmed Incorporated vs HUTCHMED (China) Limited Trends and Insights
Comparing SG&A Expenses: Catalent, Inc. vs Viking Therapeutics, Inc. Trends and Insights
Breaking Down SG&A Expenses: Walgreens Boots Alliance, Inc. vs HUTCHMED (China) Limited
Cost Management Insights: SG&A Expenses for Exelixis, Inc. and HUTCHMED (China) Limited
Pharming Group N.V. vs HUTCHMED (China) Limited: SG&A Expense Trends
Viking Therapeutics, Inc. and Perrigo Company plc: SG&A Spending Patterns Compared